🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Watch this 2 mins Oscar winning short film called "Sorry”. It is about being overloaded and individualism. I will make you think. #LiverTwitter #MedTwitter

Collaborative effort with my co-fellow/ best friend Shreesh Shrestha and others + super ⭐️ mentor = productive first year of fellowship project ✅.

NAFLD article of the week Indiana University Gastroenterology and Hepatology Nice HEPATOLOGY Journal paper from AM Diehl 1⃣Senescence ⬆️THBD-PAR1 axis ⬆️fibrogenic factors 2⃣ Inhibition of PAR1 signaling w/vorapaxar interrupts THBD-PAR1 axis 3⃣ Improves NASH and fibrosis 4⃣ ?Unitended consequences pubmed.ncbi.nlm.nih.gov/37036206/

The 3rd and final day of the Midwest Metabolic Clinical Symposium is kicked off by Penn State Health Fatty Liver PD Jonathan G. Stine, MD MSc, FACP #CME #NAFLD

Is #NASH a degenerative disease?!! Anna Mae asks us do consider this with her latest compelling work 🧐

In light of all the incredible discussions at SLU Gastroenterology & Hepatology Midwest Metabolic Clinical Symposium, I want to remind all attendees and the twitterverse that last summer American College of Sports Medicine held a roundtable about the role of physical activity in #NAFLD. Check if out👇 William Alazawi Puneet Puri

World liver day TODAY! Fight stigma, Shame ❌ 👉 barriers⬇️ 👉awareness and liver health ⬆️ We need NAFLD in the WHO action plan for NCD’s Liver diseases into policy makers agenda now❗️ Liver communities stand united💪 EASLnews ALEH AASLD APASL News Jeffrey V. Lazarus

Great opportunities at ⁦VCU Stravitz-Sanyal Institute for Liver Disease⁩ ⁦AASLD⁩ #DDW2023

Thank you, Michael Rao, Ph.D.! One team. One fight.

Honoring Diwali at the AASLD Members’ Reception ✨ #TLM23

Amazing celebration of Diwali. 🙏 AASLD. Dance w Meena Bansal Rohit Loomba Sanjaya Satapathy Arpan Patel, MD PhD (he/him/his) Monika Sarkar Neil Shah, MD Aparna Goel, MD (she/her) Binita Kamath Ajay Duseja AASLD President Norah Terrault

.Lauren Nephew MD, MSCE talking about SDOH and how they affect MASLD. A tour de force! AASLD #AASLDETC

Talking about SDOH ⁦Lauren Nephew MD, MSCE⁩ - state of the art talk on how we can help disadvantaged individuals suffering from masld & improve outcomes ⁦AASLD⁩ ⁦AASLD President⁩ ⁦Mazen Noureddin, MD, MHSc⁩ ⁦Naga Chalasani⁩ ⁦Quentin M. Anstee⁩ chairing the session

His dedication to clinical research & hard work is unmatched. He is an exceptional mentor & has been pivotal in shaping several individuals career including me A well deserved American Gastroenterological Association (AGA) Distinguished Clinician Award Proud to be a Mentee of Prof Shiv K Sarin (Shiv Sarin)

Breaking! Phase 3 ESSENCE trial results just out: Semaglutide 2.4 mg showed significant improvements for adults with #MASH-63% achieved resolution of steatohepatitis with no worsening of fibrosis vs. 34% on placebo at 72 weeks. #LiverHealth nejm.org/doi/full/10.10… NEJM

Very important paper led by Arun J. Sanyal In patients with MASH and F2-3, once-weekly semaglutide at a dose of 2.4 mg improved liver histologic results. The findings in fibrosis are very interesting and encouraging, let’s go now for ALD! #LiverTwitter #LiverX

Happening now in SDCC 32 Digestive Disease Week #Obesity and Advanced #LiverDisease With Mazen Noureddin, MD, MHSc moderating Juan Pablo (JP) Arab, MD  discussing #ETOH and obesity Puneet Puri discussing #AOM & #MASH I will discuss the role of treatments that don’t also impact obesity in MASH 🤔

Arun J. Sanyal Saul Karpen kicking off our first SSLI Research Retreat VCU Stravitz-Sanyal Institute for Liver Disease

Really inspiring 1st SSI Research Retreat at the VCU James River venue. 70 engaged motivated participants to help move all our initiatives forward. Clinical. Translational. Basic. Global. Just fantastic. Lots to do! Arun J. Sanyal , Jasmohan Bajaj , Juan Pablo (JP) Arab, MD , VCU Stravitz-Sanyal Institute for Liver Disease.